Youth with type 1 diabetes mellitus (T1DM) are regularly subjected to periods of both low (hypoglycemia) and high (hyperglycemia) blood glucose levels, as exogenous insulin therapy does not perfectly mimic endogenous insulin needs. The gene discussed is INS; the disease is diabetes mellitus.